DK1948789T3 - Fremgangsmåde til fremstilling af permanente, humane cellelinjer - Google Patents
Fremgangsmåde til fremstilling af permanente, humane cellelinjerInfo
- Publication number
- DK1948789T3 DK1948789T3 DK06818078.5T DK06818078T DK1948789T3 DK 1948789 T3 DK1948789 T3 DK 1948789T3 DK 06818078 T DK06818078 T DK 06818078T DK 1948789 T3 DK1948789 T3 DK 1948789T3
- Authority
- DK
- Denmark
- Prior art keywords
- human cell
- preparation
- cell lines
- permanent human
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/06—Uses of viruses as vector in vitro
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Molecular Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005054628A DE102005054628A1 (de) | 2005-11-16 | 2005-11-16 | Verfahren zur Herstellung von permanenten humanen Zelllinien |
| PCT/DE2006/002004 WO2007056994A2 (de) | 2005-11-16 | 2006-11-15 | Verfahren zur herstellung von permanenten humanen zelllinien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1948789T3 true DK1948789T3 (da) | 2010-10-11 |
Family
ID=37770340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06818078.5T DK1948789T3 (da) | 2005-11-16 | 2006-11-15 | Fremgangsmåde til fremstilling af permanente, humane cellelinjer |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8936908B2 (da) |
| EP (1) | EP1948789B1 (da) |
| JP (1) | JP5213719B2 (da) |
| KR (1) | KR101244529B1 (da) |
| CN (1) | CN101310014B (da) |
| AT (1) | ATE470702T1 (da) |
| AU (1) | AU2006314931B2 (da) |
| CA (1) | CA2629211C (da) |
| CY (1) | CY1110734T1 (da) |
| DE (2) | DE102005054628A1 (da) |
| DK (1) | DK1948789T3 (da) |
| ES (1) | ES2345508T3 (da) |
| IL (1) | IL190705A (da) |
| MY (1) | MY144034A (da) |
| PL (1) | PL1948789T3 (da) |
| PT (1) | PT1948789E (da) |
| SG (1) | SG173947A1 (da) |
| SI (1) | SI1948789T1 (da) |
| WO (1) | WO2007056994A2 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005054628A1 (de) | 2005-11-16 | 2007-05-24 | Cevec Pharmaceuticals Gmbh | Verfahren zur Herstellung von permanenten humanen Zelllinien |
| DE102009003439A1 (de) * | 2009-02-05 | 2010-08-26 | Cevec Pharmaceuticals Gmbh | Neue permanente humane Zelllinie |
| CN101942413B (zh) * | 2009-07-07 | 2015-02-11 | 翁炳焕 | 出生缺陷细胞库及其构建方法 |
| US20130344569A1 (en) * | 2010-08-16 | 2013-12-26 | Cevec Pharmaceuticals Gmbh | Permanent human cell lines for the production of influenza viruses |
| WO2014060594A1 (en) * | 2012-10-19 | 2014-04-24 | Cevec Pharmaceuticals Gmbh | Production of a hcmv based vaccine in human amniocyte cell lines |
| EP2722337A1 (en) * | 2012-10-19 | 2014-04-23 | CEVEC Pharmaceuticals GmbH | Production of a HCMV based vaccine in human amniocyte cell lines |
| RU2015135227A (ru) | 2013-01-22 | 2018-12-25 | Кенкор Биотех Лтд. | Способ получения рекомбинантного человеческого протромбина и фибриногена |
| WO2015192020A1 (en) | 2014-06-13 | 2015-12-17 | Children's Medical Center Corporation | Products and methods to isolate mitochondria |
| MX2017014446A (es) | 2015-05-12 | 2018-06-13 | Sangamo Therapeutics Inc | Regulacion de expresion genica mediada por nucleasa. |
| EP3294764B1 (en) * | 2015-05-15 | 2020-12-30 | City of Hope | Chimeric antigen receptor compositions |
| US11903974B2 (en) | 2015-11-30 | 2024-02-20 | Flagship Pioneering Innovations V, Inc. | Methods and compositions relating to chondrisomes from cultured cells |
| EP3736286A1 (en) | 2019-05-09 | 2020-11-11 | Biotest AG | Single chain factor viii molecule |
| JP2022546525A (ja) | 2019-09-02 | 2022-11-04 | ビオテスト・アクチエンゲゼルシャフト | 延長された半減期を有する第ｖｉｉｉ因子タンパク質 |
| EP3785726A1 (en) | 2019-09-02 | 2021-03-03 | Biotest AG | Factor viii protein with increased half-life |
| CN114929261A (zh) | 2020-02-17 | 2022-08-19 | 生物测试股份公司 | 凝血因子viii的皮下施用 |
| KR20230085929A (ko) | 2020-10-15 | 2023-06-14 | 에프. 호프만-라 로슈 아게 | Va rna 전사를 위한 핵산 구조체 |
| JP2023546113A (ja) | 2020-10-15 | 2023-11-01 | エフ． ホフマン－ラ ロシュ アーゲー | 同時遺伝子活性化のための核酸構築物 |
| WO2023060113A1 (en) | 2021-10-05 | 2023-04-13 | Regenxbio Inc. | Compositions and methods for recombinant aav production |
| CN118202060A (zh) | 2021-10-05 | 2024-06-14 | 再生生物股份有限公司 | 用于重组aav生产的组合物和方法 |
| WO2023198685A1 (en) | 2022-04-13 | 2023-10-19 | F. Hoffmann-La Roche Ag | Method for determining aav genomes |
| WO2023227438A1 (en) | 2022-05-23 | 2023-11-30 | F. Hoffmann-La Roche Ag | Raman-based method for the differentiation of aav particle serotype and aav particle loading status |
| AR129500A1 (es) | 2022-06-03 | 2024-09-04 | Hoffmann La Roche | Método para producir partículas de aav recombinante |
| WO2024013239A1 (en) | 2022-07-14 | 2024-01-18 | F. Hoffmann-La Roche Ag | Method for producing recombinant aav particles |
| WO2024056561A1 (en) | 2022-09-12 | 2024-03-21 | F. Hoffmann-La Roche Ag | Method for separating full and empty aav particles |
| WO2024165456A1 (en) | 2023-02-07 | 2024-08-15 | F. Hoffmann-La Roche Ag | Method for the detection of anti-aav particle antibodies |
| WO2024194280A1 (en) | 2023-03-21 | 2024-09-26 | F. Hoffmann-La Roche Ag | Method for the production of recombinant aav particle preparations |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6797495B2 (en) * | 1996-11-05 | 2004-09-28 | The Regents Of The University Of California | Somatic cells with ablated PrP gene and methods of use |
| US20050170463A1 (en) * | 1999-04-15 | 2005-08-04 | Abraham Bout | Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins |
| PT1161548E (pt) | 1999-04-15 | 2005-06-30 | Crucell Holland Bv | Producao de proteinas recombinantes numa celula humana utilizando sequencias codificando a proteina e1 de adenovirus |
| US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
| US6492169B1 (en) * | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
| DE19955558C2 (de) * | 1999-11-18 | 2003-03-20 | Stefan Kochanek | Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren |
| US6558948B1 (en) * | 1999-11-23 | 2003-05-06 | Stefan Kochanek | Permanent amniocytic cell line, its production and use for the production of gene transfer vectors |
| US6369448B1 (en) * | 2000-01-21 | 2002-04-09 | Lsi Logic Corporation | Vertically integrated flip chip semiconductor package |
| SI1523496T1 (sl) * | 2002-07-18 | 2011-11-30 | Merus B V | Rekombinantno proizvajanje zmesi protiteles |
| JP4865539B2 (ja) | 2003-05-09 | 2012-02-01 | クルセル ホランド ベー ヴェー | Ｅ１不死化細胞の培養物及び該培養物を培養して該培養物から得られる産物の収量を増加させる方法 |
| DE102005054628A1 (de) | 2005-11-16 | 2007-05-24 | Cevec Pharmaceuticals Gmbh | Verfahren zur Herstellung von permanenten humanen Zelllinien |
-
2005
- 2005-11-16 DE DE102005054628A patent/DE102005054628A1/de not_active Withdrawn
-
2006
- 2006-03-07 US US11/370,243 patent/US8936908B2/en active Active
- 2006-11-15 PL PL06818078T patent/PL1948789T3/pl unknown
- 2006-11-15 DE DE502006007198T patent/DE502006007198D1/de active Active
- 2006-11-15 WO PCT/DE2006/002004 patent/WO2007056994A2/de active Application Filing
- 2006-11-15 CA CA2629211A patent/CA2629211C/en active Active
- 2006-11-15 EP EP06818078A patent/EP1948789B1/de active Active
- 2006-11-15 SG SG2010093235A patent/SG173947A1/en unknown
- 2006-11-15 CN CN2006800430003A patent/CN101310014B/zh active Active
- 2006-11-15 AT AT06818078T patent/ATE470702T1/de active
- 2006-11-15 DK DK06818078.5T patent/DK1948789T3/da active
- 2006-11-15 JP JP2008540447A patent/JP5213719B2/ja active Active
- 2006-11-15 PT PT06818078T patent/PT1948789E/pt unknown
- 2006-11-15 KR KR1020087014004A patent/KR101244529B1/ko active IP Right Grant
- 2006-11-15 SI SI200630691T patent/SI1948789T1/sl unknown
- 2006-11-15 AU AU2006314931A patent/AU2006314931B2/en active Active
- 2006-11-15 ES ES06818078T patent/ES2345508T3/es active Active
-
2008
- 2008-04-08 IL IL190705A patent/IL190705A/en active IP Right Grant
- 2008-05-02 MY MYPI20081417A patent/MY144034A/en unknown
-
2010
- 2010-08-10 CY CY20101100746T patent/CY1110734T1/el unknown
-
2014
- 2014-12-19 US US14/577,881 patent/US9315773B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101310014A (zh) | 2008-11-19 |
| MY144034A (en) | 2011-07-29 |
| US20070111312A1 (en) | 2007-05-17 |
| ATE470702T1 (de) | 2010-06-15 |
| CY1110734T1 (el) | 2015-06-10 |
| SG173947A1 (en) | 2011-09-29 |
| KR20090114306A (ko) | 2009-11-03 |
| US8936908B2 (en) | 2015-01-20 |
| EP1948789B1 (de) | 2010-06-09 |
| DE502006007198D1 (de) | 2010-07-22 |
| JP5213719B2 (ja) | 2013-06-19 |
| AU2006314931B2 (en) | 2011-08-18 |
| PT1948789E (pt) | 2010-08-05 |
| KR101244529B1 (ko) | 2013-03-18 |
| WO2007056994A3 (de) | 2007-11-01 |
| JP2009515537A (ja) | 2009-04-16 |
| IL190705A0 (en) | 2011-08-01 |
| WO2007056994A2 (de) | 2007-05-24 |
| US9315773B2 (en) | 2016-04-19 |
| DE102005054628A1 (de) | 2007-05-24 |
| IL190705A (en) | 2012-04-30 |
| PL1948789T3 (pl) | 2010-11-30 |
| CA2629211C (en) | 2016-05-10 |
| WO2007056994A8 (de) | 2007-07-19 |
| SI1948789T1 (sl) | 2010-08-31 |
| CA2629211A1 (en) | 2007-05-24 |
| AU2006314931A1 (en) | 2007-05-24 |
| US20150203813A1 (en) | 2015-07-23 |
| EP1948789A2 (de) | 2008-07-30 |
| CN101310014B (zh) | 2012-05-30 |
| ES2345508T3 (es) | 2010-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1948789T3 (da) | Fremgangsmåde til fremstilling af permanente, humane cellelinjer | |
| DK1851815T3 (da) | Fremgangsmåde til fremstilling af en brændselscellekatode | |
| MX347197B (es) | Epitopes de celulas t reguladoras, composiciones y usos para los mismos. | |
| WO2009114702A3 (en) | Recombinant production of authentic human proteins using human cell expression systems | |
| DK1940918T3 (da) | Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme | |
| WO2009149956A3 (en) | Fusion protein and use thereof | |
| DE602006014676D1 (de) | Festpolymerelektrolyt-membran, herstellungsverfahren dafür und brennstoffzelle | |
| EP3539380A3 (en) | Improved cell composition and methods of making the same | |
| MX346001B (es) | Polipeptidos de eritropoyetina animal modificados y sus usos. | |
| WO2007008861A3 (en) | Methods of transferring photovoltaic cells | |
| EP2808393A3 (en) | Fucosylation-deficient cells | |
| TR201900213T4 (tr) | Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. | |
| WO2008122027A3 (en) | Novel electrode | |
| NZ584893A (en) | PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF | |
| HK1132760A1 (en) | Site specific incorporation of non-natural amino acids by vertebrate cells | |
| WO2006116181A3 (en) | Regulatory t cell mediator proteins and uses thereof | |
| MX2019003427A (es) | Composiciones para cultivo celular y metodos para la produccion de polipeptidos. | |
| WO2009049284A3 (en) | Compositions and methods for improved glycoprotein sialylation | |
| EP2516624A4 (en) | CELL LINE 3M | |
| WO2012068317A3 (en) | Methods for producing recombinant proteins | |
| BRPI0819649A2 (pt) | método, organismo geneticamente modificado, e, célula de levedura recinbinante | |
| DK1511761T3 (da) | Fremgangsmåde til fremstilling af cykliske peptider | |
| MX2010007716A (es) | Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas. | |
| BR112015021993A2 (pt) | composições de cultura celular com antioxidantes e métodos para produção de polipeptídeo | |
| EP1963506A4 (en) | COMPOSITIONS AND METHODS FOR INCREASING THE PRODUCTION OF RECOMBINANT GAMMA-CARBOXYLATED PROTEINS |